## HIG: The Hartford Insurance Group, I - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.41 indicates fundamental undervaluation. Quality metrics strong (ROE 20%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-5.2% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($131.22)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. XTX Topco Ltd Raises Holdings in The Hartford Insurance Group, Inc. $HIG**
- Source: MarketBeat | 20251129T115123 | Bullish | Relevance: 100%
- XTX Topco Ltd significantly increased its stake in The Hartford Insurance Group, Inc. by 90.8% to 15,894 shares, valued at $2.02 million. This comes as The Hartford reported strong quarterly earnings, beating consensus estimates, and raised its quarterly dividend. The article also details other institutional investor activity, stock performance metrics, analyst ratings, and recent insider transactions for HIG.

**2. Russell Investments Group Ltd. Trims Stake in The Hartford Insurance Group, Inc. $HIG**
- Source: MarketBeat | 20251130T111057 | Somewhat-Bullish | Relevance: 99%
- Russell Investments Group Ltd. trimmed its stake in The Hartford Insurance Group, Inc. (NYSE:HIG) by 13.0% in the second quarter, selling 52,612 shares and ending with 351,998 shares valued at approximately $44.57 million. Despite this reduction, analysts maintain a "Moderate Buy" consensus with an average price target of $143.29, following the company's beat on earnings and a dividend increase. The article also details other institutional investor activity, analyst ratings, stock performance, and recent insider transactions.

**3. The Hartford Insurance Group, Inc. $HIG Shares Acquired by Vinva Investment Management Ltd**
- Source: MarketBeat | 20251130T131048 | Bullish | Relevance: 99%
- Vinva Investment Management Ltd significantly increased its stake in The Hartford Insurance Group, Inc. by 33.8%, now holding 19,171 shares worth $2.39 million. Several other major institutional investors also boosted their positions, contributing to an overall institutional ownership of 93.42%. The company reported strong financial performance, beating quarterly EPS expectations and raising its quarterly dividend.

**4. F m Investments LLC Cuts Stake in The Hartford Insurance Group, Inc. $HIG**
- Source: MarketBeat | 20251129T133012 | Somewhat-Bullish | Relevance: 99%
- F m Investments LLC reduced its stake in The Hartford Insurance Group by 13.2% in the second quarter, selling over 11,000 shares, though institutional investors collectively own a significant 93.42% of the stock. Meanwhile, The Hartford reported strong quarterly earnings, beating analyst expectations, and increased its quarterly dividend. The company also received several positive analyst ratings with a "Moderate Buy" consensus.

**5. The Hartford Insurance Group, Inc. $HIG Shares Sold by Northwest & Ethical Investments L.P.**
- Source: MarketBeat | 20251129T114421 | Somewhat-Bullish | Relevance: 98%
- Northwest & Ethical Investments L.P. significantly reduced its stake in The Hartford Insurance Group by 85.4% during the second quarter. Despite this, The Hartford reported strong quarterly earnings, exceeding expectations with 7.1% year-over-year revenue growth, and increased its quarterly dividend. Analysts maintain a generally positive outlook, with several increasing price targets and assigning "buy" or "overweight" ratings for the company.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | UBS | $155 | $151 | +3% |
| 2025-11-25 | Argus Research | $155 | $143 | +8% |
| 2025-11-17 | Morgan Stanley | $150 | $140 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | UBS | main | Buy |
| 2025-11-25 | Argus Research | main | Buy |
| 2025-11-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($0.96M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (-0.8%)
- Blackrock Inc.: 10.9% (-4.4%)
- State Street Corpora: 5.8% (+0.3%)
- FMR, LLC: 4.9% (+13.2%)
- Price (T.Rowe) Assoc: 3.1% (-11.5%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 3 raises (avg +6%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.41 suggests fair value with growth premium. Quality metrics strong (ROE 20%). Balance sheet: strong liquidity (17.8x), $1.8B free cash flow. Analyst sentiment positive (3 raises, avg +6%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $36.6B |
| Beta | 0.63 |
| 52W Range | $104.93 - $138.64 |
| Short Interest | 2.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.41 |
| Forward P/E | 10.2 |
| Current P/E | 10.8 |
| YoY Growth | 5.2% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 6.3% to 1.1% (-5.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.9pp (needs >4.0% for momentum thesis). MRS_5 (-1.3%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.09% (CS: 63) | Neutral |
| RSI_14 | 61.5 | Neutral |
| MACD Histogram | 0.42 | Bullish |
| vs SMA20 | 1.022x | Above |
| vs SMA50 | 1.040x | Above |
| vs SMA200 | 1.077x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $135.50
- **Stop Loss:** $131.22 (3.2% risk)
- **Target:** $144.06 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 233
- **Position Value:** $31,571.50
- **Portfolio %:** 31.57%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-01-29 (Est: $3.17)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.21 | $3.78 | +17.6% |
| 2025Q2 | $2.83 | $3.41 | +20.4% |
| 2025Q1 | $2.15 | $2.20 | +2.5% |
| 2024Q4 | $2.64 | $2.94 | +11.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*